Press release
Tumor Ablation Market is expected to rise at a CAGR of 13.3% by 2032, estimates DelveInsight
Tumor Ablation Market, DelveInsight
DelveInsight's Tumor Ablation Market Insights report provides the current and forecast market analysis, individual leading Tumor Ablation companies' market shares, challenges, Tumor Ablation market drivers, barriers, and trends, and key Tumor Ablation companies in the market.
Request for a sample page report @ https://www.delveinsight.com/report-store/tumor-ablation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Tumor Ablation Market Report
The Tumor Ablation market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Tumor Ablation market during the forecast period.
Notable Tumor Ablation companies such as Medtronic PLC, Stryker, Baird Medical Devices Inc., Siemens Healthineers AG, Compal Electronics, Novian Health Inc., Boston Scientific, Merit Medical Systems, Johnson & Johnson, Abbott., Olympus Corporation, Bioventus Inc., AngioDynamics, Mermaid Medical, HealthTronics, Inc., HealthTronics, Inc., AtriCure, Inc., Hologic, Inc., Smith & Nephew, Hologic, Inc., and several others are currently operating in the Tumor Ablation market.
In March 2024, Medtronic obtained FDA clearance for its OsteoCoolTM 2.0 Bone Tumor Ablation System.
In September 2022, Stryker received FDA approval for the OptaBlateTM Bone Tumor Ablation System.
To read more about the latest highlights related to the Tumor Ablation market, get a snapshot of the key highlights entailed in the Global Tumor Ablation Market Report https://www.delveinsight.com/sample-request/tumor-ablation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Tumor Ablation Overview
Tumor ablation is a minimally invasive treatment technique used to destroy cancerous tissue using extreme heat, cold, or other energy sources. The method is widely applied in the management of solid tumors, particularly in organs such as the liver, kidney, lungs, and bones, where conventional surgery may be risky or unsuitable.
Tumor Ablation Market Insights
North America is projected to hold the largest share of the tumor ablation market in 2024. The region's high cancer burden-particularly liver, kidney, and lung cancers-continues to drive demand for advanced therapeutic options such as tumor ablation. Well-established healthcare infrastructure, early adoption of minimally invasive procedures, and favorable reimbursement policies further support market growth. In addition, continuous technological advancements in radiofrequency and microwave ablation systems, along with strong investments in R&D and collaborations among leading industry players, are accelerating innovation and reinforcing North America's market dominance.
According to GLOBOCAN (2024), North America reported approximately 79,800 new kidney cancer cases in 2022, with projections rising to about 103,000 by 2045. Overall, the region recorded 2.67 million new cancer cases in 2022, expected to grow to 3.83 million by 2045. The rising incidence of cancers such as liver, kidney, and lung underscores the growing need for effective, minimally invasive treatment approaches. Tumor ablation therapies, including radiofrequency and microwave ablation, provide targeted solutions with shorter recovery times, making them increasingly preferred over conventional surgery.
To know more about why North America is leading the market growth in the Tumor Ablation market, get a snapshot of the Tumor Ablation Market Outlook https://www.delveinsight.com/report-store/tumor-ablation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Tumor Ablation Market Dynamics
According to the World Cancer Research Fund (2024), over 866,136 new cases of liver cancer were reported globally in 2022. Similarly, GLOBOCAN (2024) estimated 435,000 new cases of kidney cancer in 2022, with projections suggesting a rise to nearly 693,000 cases by 2045.
Tumor ablation methods, including radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, are particularly effective for localized tumors in organs like the liver and kidneys, where conventional surgeries may be riskier or unsuitable due to patient comorbidities. The high global incidence of liver cancer, especially hepatocellular carcinoma (HCC), has fueled demand for ablation therapies, often used in early-stage cases or when surgical resection is not feasible. Likewise, the growing burden of kidney cancer, mainly renal cell carcinoma, is driving adoption of tumor ablation as a nephron-sparing approach that preserves kidney function while effectively targeting malignant cells. Together, these factors are significantly contributing to the expansion of the tumor ablation market worldwide.
Tumor Ablation Market Drivers:
Rising prevalence of cancer
Increase in preference for minimally invasive procedures
Increase in technological advancements in tumor ablation devices
Increasing strategic activities among the key players across the globe
Get a sneak peek at the Tumor Ablation market dynamics @ https://www.delveinsight.com/sample-request/tumor-ablation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Scope of the Tumor Ablation Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Tumor Ablation Companies: Medtronic PLC, Stryker, Baird Medical Devices Inc., Siemens Healthineers AG, Compal Electronics, Novian Health Inc., Boston Scientific, Merit Medical Systems, Johnson & Johnson, Abbott., Olympus Corporation, Bioventus Inc., AngioDynamics, Mermaid Medical, HealthTronics, Inc., HealthTronics, Inc., AtriCure, Inc., Hologic, Inc., Smith & Nephew, Hologic, Inc., and others.
Which MedTech key players in the Tumor Ablation market are set to emerge as the trendsetter, explore @ Tumor Ablation Companies https://www.delveinsight.com/report-store/tumor-ablation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Info:
Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tumor Ablation Market is expected to rise at a CAGR of 13.3% by 2032, estimates DelveInsight here
News-ID: 4148472 • Views: …
More Releases from DelveInsight Business Research LLP
Real World Evidence Solution Market is expected to rise at a CAGR of 8.07% by 20 …
The global real-world evidence (RWE) solutions market was valued at USD 2,832.33 million in 2024 and is projected to grow at a CAGR of 8.07% between 2025 and 2032, reaching USD 5,240.07 million by 2032. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing reliance on real-world data to understand their impact. Advancements in technologies such as big data analytics, artificial intelligence, and machine…
Gene Therapy Market is expected to rise at a CAGR of 19.25% by 2032, estimates D …
The global gene therapy market was valued at USD 8,570.28 million in 2024 and is projected to grow at a CAGR of 19.25% from 2025 to 2032, reaching USD 34,933.71 million by 2032. The increasing prevalence of genetic and rare diseases has fueled demand for innovative therapeutic solutions, positioning gene therapy as a key treatment option. This growth is further supported by an expanding pipeline of gene therapies, including numerous…
High Flow Oxygen Therapy Devices Market is expected to rise at a CAGR of 2.31% b …
The global high-flow oxygen therapy (HFOT) devices market is projected to expand at a CAGR of 2.31% between 2025 and 2032. Rising incidences of respiratory conditions such as COPD, asthma, pneumonia, and Acute Respiratory Distress Syndrome (ARDS) are driving demand for HFOT devices, as healthcare providers increasingly adopt non-invasive treatment options. At the same time, the growth of home healthcare and telemedicine is improving access to these devices, allowing patients…
Spinal Implants Market is expected to rise at a CAGR of 5.5% by 2032, estimates …
The global spinal implants market was valued at USD 14,324.12 million in 2024 and is projected to grow at a CAGR of 5.50% from 2025 to 2032, reaching USD 21,899.24 million by 2032. The increasing prevalence of spinal disorders, particularly among the elderly, is driving demand for surgical corrections. Additionally, the rise in sports-related and trauma-induced spinal injuries is contributing to the need for advanced implantable solutions. There is also…
More Releases for Tumor
Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Carcinoid Tumor Market Size During the Forecast Period?
In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.…
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg
Brain Tumor Foundation
October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis
NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.…
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949
This latest report researches the industry structure,…
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights
The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market.
Request Access Global Wilms Tumor Market…
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments…
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally.
ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the…
